These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8559381)

  • 21. Short-latency somatosensory evoked potentials in myotonic dystrophy: evidence for a conduction disturbance.
    Gott PS; Karnaze DS
    Electroencephalogr Clin Neurophysiol; 1985 Nov; 62(6):455-8. PubMed ID: 2415342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.
    Benders AA; Timmermans JA; Oosterhof A; Ter Laak HJ; van Kuppevelt TH; Wevers RA; Veerkamp JH
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):269-74. PubMed ID: 8392337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myotonic dystrophy.
    Tanaka K
    Med Hypotheses; 1985 Aug; 17(4):415-25. PubMed ID: 4046909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal and postnatal maturation of medullary 'respiratory centers'.
    Takashima S; Becker LE
    Brain Res; 1986 May; 391(2):173-7. PubMed ID: 3697771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperparathyroidism in patients with myotonic dystrophy.
    Yoshida H; Oshima H; Saito E; Kinoshita M
    J Clin Endocrinol Metab; 1988 Sep; 67(3):488-92. PubMed ID: 2842360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions.
    Censori B; Provinciali L; Danni M; Chiaramoni L; Maricotti M; Foschi N; Del Pesce M; Salvolini U
    Acta Neurol Scand; 1994 Sep; 90(3):211-7. PubMed ID: 7847063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal regulation of parathyroid hormone secretion by serum calcium level in myotonic dystrophy].
    Yoshida H
    Nihon Naibunpi Gakkai Zasshi; 1988 Jul; 64(7):547-53. PubMed ID: 3220153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracytoplasmic inclusion bodies of the substantia nigra in myotonic dystrophy. Immunohistochemical observations.
    Ono S; Takahashi K; Fukuoka Y; Jinnai K; Kanda F; Kurisaki H; Mitake S; Inagaki T; Nagao K
    J Neurol Sci; 1997 May; 148(2):193-8. PubMed ID: 9129116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound imaging of the masseter muscle in myotonic dystrophy patients.
    Kiliaridis S; Engvall M; Tzakis MG
    J Oral Rehabil; 1995 Aug; 22(8):619-25. PubMed ID: 7472735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Abnormal calcium metabolism in myotonic dystrophy: increased level of serum 1,25(OH)2D concentration and augmented intestinal calcium absorption].
    Oshima H; Kinoshita M; Yoshida H; Saito E
    Nihon Naibunpi Gakkai Zasshi; 1986 Oct; 62(10):1203-11. PubMed ID: 3803629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrically-elicited surface mechanomyogram in myotonic dystrophy.
    Orizio C; Esposito F; Paganotti I; Marino L; Rossi B; Veicsteinas A
    Ital J Neurol Sci; 1997 Aug; 18(4):185-90. PubMed ID: 9323511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myotonic dystrophy and progressive cognitive decline: a common condition or two separate problems?
    Wilson BA; Balleny H; Patterson K; Hodges JR
    Cortex; 1999 Feb; 35(1):113-21. PubMed ID: 10213538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Central nervous system disorders in myotonic dystrophy--with special reference to neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme levels in CSF].
    Yoneyama S; Mokuno K; Matsuoka Y; Takahashi A; Kato K
    Rinsho Shinkeigaku; 1992 Jun; 32(6):572-6. PubMed ID: 1424333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte IgG-Fc receptors in myotonic dystrophy.
    Banerjee D; McClintock J; Silver MM; Hudson AJ
    Clin Exp Immunol; 1982 Dec; 50(3):572-8. PubMed ID: 7166000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cerebral glucose utilization in myotonic dystrophy.
    Fiorelli M; Duboc D; Mazoyer BM; Blin J; Eymard B; Fardeau M; Samson Y
    Neurology; 1992 Jan; 42(1):91-4. PubMed ID: 1734329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular motor myotonic phenomenon in myotonic dystrophy.
    Versino M; Rossi B; Beltrami G; Sandrini G; Cosi V
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):236-40. PubMed ID: 11796775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of erythrocyte membrane phospholipid in patients with early-onset myotonic dystrophy.
    Eda I; Takeshita K
    Brain Dev; 1984; 6(3):284-8. PubMed ID: 6486376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Movement-related cortical potentials in myotonic dystrophy.
    Mitsuoka T; Watanabe C; Kitamura J; Ishigame K; Nakamura S
    Clin Neurophysiol; 2003 Jan; 114(1):99-106. PubMed ID: 12495770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin abnormalities in patients with myotonic dystrophy.
    Suzumura A; Yamada H; Matsuoka Y; Sobue I
    Acta Neurol Scand; 1986 Aug; 74(2):132-9. PubMed ID: 3490729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abnormalities of N-linked oligosaccharide moieties of glycoproteins in patients with myotonic dystrophy].
    Ito K; Takahashi N; Takano A; Honda H
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1484-5. PubMed ID: 8752438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.